We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+13.13%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$1.11B
AUM Growth
+$28.9M
Cap. Flow
-$70.4M
Cap. Flow %
-6.34%
Top 10 Hldgs %
20.71%
Holding
564
New
93
Increased
113
Reduced
193
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Financials 9.74%
3 Healthcare 8.27%
4 Industrials 8.16%
5 Consumer Discretionary 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTN icon
226
Gray Television
GTN
$507M
$402K 0.04%
22,463
-249
-1% -$3.95K
IWV icon
227
iShares Russell 3000 ETF
IWV
$20.2B
$401K 0.04%
1,795
NRG icon
228
NRG Energy
NRG
$24.4B
$384K 0.03%
10,225
-35,273
-78% -$1.16M
FPXI icon
229
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$293M
$368K 0.03%
+5,350
New +$330K
CHD icon
230
Church & Dwight Co
CHD
$24.4B
$360K 0.03%
4,128
+113
+3% +$10K
AFG icon
231
American Financial Group
AFG
$12B
$351K 0.03%
4,005
-629
-14% -$51.6K
KLIC icon
232
Kulicke & Soffa
KLIC
$4.44B
$346K 0.03%
10,871
-413
-4% -$12K
LXP icon
233
LXP Industrial Trust
LXP
$3.6B
$345K 0.03%
+6,500
New +$343K
CVS icon
234
CVS Health
CVS
$121B
$339K 0.03%
4,960
-71,158
-93% -$4.63M
CCI icon
235
Crown Castle
CCI
$32.1B
$334K 0.03%
2,100
-17,835
-89% -$2.89M
EFA icon
236
iShares MSCI EAFE ETF
EFA
$80B
$325K 0.03%
4,450
+1,850
+71% +$127K
HLI icon
237
Houlihan Lokey
HLI
$9.07B
$316K 0.03%
+4,700
New +$305K
KMDA icon
238
Kamada
KMDA
$483M
$314K 0.03%
48,510
+50
+0.1% +$355
KBA icon
239
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$145M
$295K 0.03%
6,424
-3,925
-38% -$168K
LDOS icon
240
Leidos
LDOS
$17.2B
$281K 0.03%
2,670
+120
+5% +$11.5K
WMK icon
241
Weis Markets
WMK
$1.75B
$280K 0.03%
5,855
-1,500
-20% -$72K
BAC.PRM icon
242
Bank of America Depository Shares Series KK
BAC.PRM
$1.12B
$273K 0.02%
10,000
-4,000
-29% -$109K
IDNA icon
243
iShares Genomics Immunology and Healthcare ETF
IDNA
$254M
$259K 0.02%
5,627
VNDA icon
244
Vanda Pharmaceuticals
VNDA
$323M
$259K 0.02%
19,710
+25
+0.1% +$301
POR icon
245
Portland General Electric
POR
$5.9B
$254K 0.02%
5,935
-450
-7% -$18.3K
INDA icon
246
iShares MSCI India ETF
INDA
$6.64B
$250K 0.02%
+6,218
New +$227K
USLM icon
247
United States Lime & Minerals
USLM
$3.39B
$236K 0.02%
+10,350
New +$214K
CLF icon
248
Cleveland-Cliffs
CLF
$6.58B
$233K 0.02%
16,000
IEA
249
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$232K 0.02%
14,000
NUO
250
DELISTED
Nuveen Ohio Quality Municipal Income Fund
NUO
$228K 0.02%
14,575
+2,900
+25% +$44.6K

Similar funds

James Investment Research's Q4 2020 Portfolio in Review

As of Q4 2020, James Investment Research held 564 positions worth $1.11B, up 2.7% from $1.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

James Investment Research withdrew a net $70.4M in Q4 2020, closing 56 positions and reducing 193 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $4.67M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, James Investment Research opened a new position in Vanguard Morningstar Small-Cap Value ETF worth $15.4M.

  • James Investment Research's largest Q4 2020 buy was Vanguard Morningstar Small-Cap Value ETF: 108,050 shares worth $15.4M.
  • James Investment Research added most to iShares Russell 2000 Value ETF in Q4 2020, an estimated $15.2M increase.
  • James Investment Research's biggest Q4 2020 reduction was Microsoft, cutting an estimated $11.7M.
  • James Investment Research fully exited Regeneron Pharmaceuticals in Q4 2020, selling an estimated $4.67M.
  • James Investment Research's ten largest holdings make up 21% of its $1.11B portfolio in Q4 2020.
  • James Investment Research opened 93 new positions and closed 56 in Q4 2020.
  • James Investment Research's portfolio value rose 2.7% quarter-over-quarter to $1.11B.

Based on James Investment Research's 13F filing for Q4 2020, filed 27 Jan 2021.